---
title: "Fatty15 Co-Founder, Dr. Stephanie Venn-Watson, Named 2026 LA Times Life Sciences Visionary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284394148.md"
description: "Seraphina Therapeutics, based in San Diego, has recently gained scientific recognition for uncovering an emerging nutritional deficiency syndrome linked to C15:0. The discovery, made during efforts to enhance the health of aging Navy dolphins, showcases the importance of addressing this condition. The findings were announced on April 28, 2026, shedding light on the significance of this breakthrough in the field of nutrition and health."
datetime: "2026-04-28T13:01:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284394148.md)
  - [en](https://longbridge.com/en/news/284394148.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284394148.md)
---

# Fatty15 Co-Founder, Dr. Stephanie Venn-Watson, Named 2026 LA Times Life Sciences Visionary

Seraphina Therapeutics, based in San Diego, has recently gained scientific recognition for uncovering an emerging nutritional deficiency syndrome linked to C15:0. The discovery, made during efforts to enhance the health of aging Navy dolphins, showcases the importance of addressing this condition. The findings were announced on April 28, 2026, shedding light on the significance of this breakthrough in the field of nutrition and health.

### Related Stocks

- [SER.US](https://longbridge.com/en/quote/SER.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)

## Related News & Research

- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Cardiff Oncology updates Phase 2 onvansertib data in first-line RAS-mutated mCRC trial](https://longbridge.com/en/news/287272648.md)
- [Nuvalent to present pivotal ALKOVE-1 neladalkib data in ALK-positive NSCLC at ASCO 2026](https://longbridge.com/en/news/287275055.md)
- [Black Diamond reports Phase 2 silevertinib mPFS 15.2 months in frontline EGFR-mutant NSCLC](https://longbridge.com/en/news/287274011.md)
- [Neurothera Labs Announces Adoption of Semi-Annual Reporting](https://longbridge.com/en/news/287119698.md)